DESIGN THERAPEUTICS INC (DSGN) Stock Balance Sheet
NASDAQ:DSGN - US25056L1035 - Common Stock
6.45 USD
+0.34 (+5.56%)
6.45 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 19.70M | 22.56M | 21.20M | 26.50M | 298.60M | |||
| Marketable Securities | 196.57M | 222.91M | 260.60M | 303.90M | 85.50M | |||
| Receivables | 1.35M | 1.26M | 1.43M | N/A | N/A | |||
| Other Current Assets | 2.17M | 1.30M | 1.35M | 4.70M | 1.40M | |||
| Total Current Assets | 219.79M | 248.04M | 284.58M | 335.10M | 385.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.09M | 3.63M | 4.63M | 5.60M | 5.10M | |||
| Other Non-Current Assets | 0.00 | 427.00K | 430.00K | 500.00K | 0.00 | |||
| Total Non-Current Assets | 3.09M | 4.05M | 5.06M | 6.00M | 5.20M | |||
| TOTAL ASSETS | 222.89M | 252.09M | 289.64M | 341.10M | 390.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.73M | 6.28M | 7.68M | 7.80M | 3.70M | |||
| Accounts Payable | 1.01M | 2.19M | 1.94M | 3.00M | 1.60M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 8.75M | 8.46M | 9.62M | 10.80M | 5.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.10M | 1.53M | 2.33M | 3.10M | 3.10M | |||
| Total Non-Current Liabilities | 1.10M | 1.53M | 2.33M | 3.00M | 3.10M | |||
| TOTAL LIABILITIES | 9.85M | 10.00M | 11.96M | 13.80M | 8.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -264.01M | -227.21M | -177.63M | -110.80M | -47.50M | |||
| Additional Paid In Capital | 476.74M | 468.83M | 455.25M | 441.40M | 429.80M | |||
| Common Shares | 6.00K | 6.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 305.00K | 475.00K | 62.00K | -3.40M | -200.00K | |||
| Shares Outstanding | 56.95M | 56.75M | 56.47M | 55.90M | 55.40M | |||
| Tangible Book Value per Share | 3.74 | 4.27 | 4.92 | 5.86 | 6.90 | |||
| Total Shareholders' Equity | 213.04M | 242.10M | 277.69M | 327.30M | 382.10M | |||
| TOTAL LIABILITIES AND EQUITY | 222.89M | 252.09M | 289.64M | 341.10M | 390.60M | |||
| Statistics | ||||||||
| Current Ratio | 25.13 | 29.31 | 29.58 | 31.03 | 72.72 | |||
| Return On Assets (ROA) | -28.48% | -19.83% | -23.13% | -18.56% | -9.10% | |||
| Return On Equity (ROE) | -29.80% | -20.65% | -24.13% | -19.34% | -9.30% | |||
All data in USD , ROIC based on taxRate of 0.21